Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage.
Evaluation of patients with IVF implantation failure or recurrent miscarriage often frustratingly fails to elicit any particular cause for their problem. Testing for antiphospholipid antibodies or thrombophilia is commonly carried out, and interpretation of results in the light of the current evidence is extremely difficult. This paper reviews the purported pathogenetic mechanisms and clinical associations between both antiphospholipid antibodies and inherited thrombophilias, and reproductive failure. The current management strategies are also critically evaluated and recommendations are made for optimal, evidence-based clinical practice.
Stern
Catharyn
C
Royal Women's Hospital and Melbourne IVF, Melbourne, Australia. kate.stern@mivf.com.au
Chamley
Larry
L
D000026:Abortion, Habitual / Q000097:blood* / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D000925:Anticoagulants / Q000627:therapeutic use; D010064:Embryo Implantation / Q000276:immunology*; D019317:Evidence-Based Medicine; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007247:Infertility, Female / Q000209:etiology / Q000276:immunology; D011247:Pregnancy; D019851:Thrombophilia / Q000097:blood* / Q000150:complications / Q000235:genetics / Q000628:therapy; D017211:Treatment Failure
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D016756:Immunoglobulins, Intravenous